LymphedemaV1, Ncbi, Merge, bibRecord, 000773

[Rosacea in the year 2001].

Identifieur interne : 000773 ( Ncbi/Merge ); précédent : 000772; suivant : 000774

[Rosacea in the year 2001].

Auteurs : M R Thissen [Pays-Bas] ; H A Neumann

Source :

Nederlands tijdschrift voor geneeskunde [ 0028-2162 ] ; 2001.

RBID : pubmed:11582639

Descripteurs français

KwdFr :
- Adulte, Anti-infectieux (administration et posologie), Coagulation par laser, Diagnostic différentiel, Femelle, Humains, Lymphoedème (étiologie), Mâle, Pays-Bas (épidémiologie), Rhinophyma (étiologie), Rosacée (), Rosacée (diagnostic), Rosacée (épidémiologie), Répartition par sexe, Télangiectasie (étiologie), Érythème (étiologie).
MESH :
- administration et posologie : Anti-infectieux.
- diagnostic : Rosacée.
- épidémiologie : Pays-Bas, Rosacée.
- étiologie : Lymphoedème, Rhinophyma, Télangiectasie, Érythème.
- Adulte, Coagulation par laser, Diagnostic différentiel, Femelle, Humains, Mâle, Rosacée, Répartition par sexe.
Wicri :
- geographic : Pays-Bas.

English descriptors

KwdEn :
- Adult, Anti-Infective Agents (administration & dosage), Diagnosis, Differential, Erythema (etiology), Female, Humans, Laser Coagulation, Lymphedema (etiology), Male, Netherlands (epidemiology), Rhinophyma (etiology), Rosacea (complications), Rosacea (diagnosis), Rosacea (epidemiology), Rosacea (therapy), Sex Distribution, Telangiectasis (etiology).
MESH :
- chemical , administration & dosage : Anti-Infective Agents.
- geographic , epidemiology : Netherlands.
- complications : Rosacea.
- diagnosis : Rosacea.
- epidemiology : Rosacea.
- etiology : Erythema, Lymphedema, Rhinophyma, Telangiectasis.
- therapy : Rosacea.
- Adult, Diagnosis, Differential, Female, Humans, Laser Coagulation, Male, Sex Distribution.

Abstract

Rosacea is a chronic skin disorder of the face. Initially erythema and telangiectasia develop, followed at a later stage by papules and papulopustules. Females between 30 and 50 years of age are most affected. Pathogenesis is not clearly understood. Finally rhinophyma and persistent lymphoedema can develop. It can be difficult to distinguish acne vulgaris, seborrheic eczema, perioral dermatitis and lupus erythematosus from rosacea. Treatment of first choice consists of topically or systemically applied antibiotics. More severe cases can be treated with isotretinoin. Erythema and telangiectasia respond well to treatment with vascular lasers.

PubMed: 11582639

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 004731
to stream PubMed, to step Curation: 004731
to stream PubMed, to step Checkpoint: 004731

Links to Exploration step

pubmed:11582639

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Rosacea in the year 2001].</title>
<author><name sortKey="Thissen, M R" sort="Thissen, M R" uniqKey="Thissen M" first="M R" last="Thissen">M R Thissen</name>
<affiliation wicri:level="1"><nlm:affiliation>Academisch Ziekenhuis, afd. Dermatologie, Postbus 5800, 6202 AZ Maastricht. mthis@sder.azm.nl</nlm:affiliation>
<country wicri:rule="url">Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Neumann, H A" sort="Neumann, H A" uniqKey="Neumann H" first="H A" last="Neumann">H A Neumann</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11582639</idno>
<idno type="pmid">11582639</idno>
<idno type="wicri:Area/PubMed/Corpus">004731</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004731</idno>
<idno type="wicri:Area/PubMed/Curation">004731</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004731</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004731</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004731</idno>
<idno type="wicri:Area/Ncbi/Merge">000773</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Rosacea in the year 2001].</title>
<author><name sortKey="Thissen, M R" sort="Thissen, M R" uniqKey="Thissen M" first="M R" last="Thissen">M R Thissen</name>
<affiliation wicri:level="1"><nlm:affiliation>Academisch Ziekenhuis, afd. Dermatologie, Postbus 5800, 6202 AZ Maastricht. mthis@sder.azm.nl</nlm:affiliation>
<country wicri:rule="url">Pays-Bas</country>
</affiliation>
</author>
<author><name sortKey="Neumann, H A" sort="Neumann, H A" uniqKey="Neumann H" first="H A" last="Neumann">H A Neumann</name>
</author>
</analytic>
<series><title level="j">Nederlands tijdschrift voor geneeskunde</title>
<idno type="ISSN">0028-2162</idno>
<imprint><date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anti-Infective Agents (administration & dosage)</term>
<term>Diagnosis, Differential</term>
<term>Erythema (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Laser Coagulation</term>
<term>Lymphedema (etiology)</term>
<term>Male</term>
<term>Netherlands (epidemiology)</term>
<term>Rhinophyma (etiology)</term>
<term>Rosacea (complications)</term>
<term>Rosacea (diagnosis)</term>
<term>Rosacea (epidemiology)</term>
<term>Rosacea (therapy)</term>
<term>Sex Distribution</term>
<term>Telangiectasis (etiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Anti-infectieux (administration et posologie)</term>
<term>Coagulation par laser</term>
<term>Diagnostic différentiel</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème (étiologie)</term>
<term>Mâle</term>
<term>Pays-Bas (épidémiologie)</term>
<term>Rhinophyma (étiologie)</term>
<term>Rosacée ()</term>
<term>Rosacée (diagnostic)</term>
<term>Rosacée (épidémiologie)</term>
<term>Répartition par sexe</term>
<term>Télangiectasie (étiologie)</term>
<term>Érythème (étiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Infective Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Netherlands</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Anti-infectieux</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Rosacea</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Rosacea</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Rosacée</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Rosacea</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Erythema</term>
<term>Lymphedema</term>
<term>Rhinophyma</term>
<term>Telangiectasis</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Rosacea</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Pays-Bas</term>
<term>Rosacée</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
<term>Rhinophyma</term>
<term>Télangiectasie</term>
<term>Érythème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Diagnosis, Differential</term>
<term>Female</term>
<term>Humans</term>
<term>Laser Coagulation</term>
<term>Male</term>
<term>Sex Distribution</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Coagulation par laser</term>
<term>Diagnostic différentiel</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Rosacée</term>
<term>Répartition par sexe</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Pays-Bas</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Rosacea is a chronic skin disorder of the face. Initially erythema and telangiectasia develop, followed at a later stage by papules and papulopustules. Females between 30 and 50 years of age are most affected. Pathogenesis is not clearly understood. Finally rhinophyma and persistent lymphoedema can develop. It can be difficult to distinguish acne vulgaris, seborrheic eczema, perioral dermatitis and lupus erythematosus from rosacea. Treatment of first choice consists of topically or systemically applied antibiotics. More severe cases can be treated with isotretinoin. Erythema and telangiectasia respond well to treatment with vascular lasers.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11582639</PMID>
<DateCreated><Year>2001</Year>
<Month>10</Month>
<Day>03</Day>
</DateCreated>
<DateCompleted><Year>2001</Year>
<Month>10</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-2162</ISSN>
<JournalIssue CitedMedium="Print"><Volume>145</Volume>
<Issue>37</Issue>
<PubDate><Year>2001</Year>
<Month>Sep</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>Nederlands tijdschrift voor geneeskunde</Title>
<ISOAbbreviation>Ned Tijdschr Geneeskd</ISOAbbreviation>
</Journal>
<ArticleTitle>[Rosacea in the year 2001].</ArticleTitle>
<Pagination><MedlinePgn>1778-82</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Rosacea is a chronic skin disorder of the face. Initially erythema and telangiectasia develop, followed at a later stage by papules and papulopustules. Females between 30 and 50 years of age are most affected. Pathogenesis is not clearly understood. Finally rhinophyma and persistent lymphoedema can develop. It can be difficult to distinguish acne vulgaris, seborrheic eczema, perioral dermatitis and lupus erythematosus from rosacea. Treatment of first choice consists of topically or systemically applied antibiotics. More severe cases can be treated with isotretinoin. Erythema and telangiectasia respond well to treatment with vascular lasers.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thissen</LastName>
<ForeName>M R</ForeName>
<Initials>MR</Initials>
<AffiliationInfo><Affiliation>Academisch Ziekenhuis, afd. Dermatologie, Postbus 5800, 6202 AZ Maastricht. mthis@sder.azm.nl</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Neumann</LastName>
<ForeName>H A</ForeName>
<Initials>HA</Initials>
</Author>
</AuthorList>
<Language>dut</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Rosacea anno 2001.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Ned Tijdschr Geneeskd</MedlineTA>
<NlmUniqueID>0400770</NlmUniqueID>
<ISSNLinking>0028-2162</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004890" MajorTopicYN="N">Erythema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017075" MajorTopicYN="N">Laser Coagulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012224" MajorTopicYN="N">Rhinophyma</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012393" MajorTopicYN="Y">Rosacea</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013684" MajorTopicYN="N">Telangiectasis</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>22</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year>
<Month>10</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2001</Year>
<Month>10</Month>
<Day>26</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2001</Year>
<Month>10</Month>
<Day>5</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">11582639</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Pays-Bas</li>
</country>
</list>
<tree><noCountry><name sortKey="Neumann, H A" sort="Neumann, H A" uniqKey="Neumann H" first="H A" last="Neumann">H A Neumann</name>
</noCountry>
<country name="Pays-Bas"><noRegion><name sortKey="Thissen, M R" sort="Thissen, M R" uniqKey="Thissen M" first="M R" last="Thissen">M R Thissen</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000773 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000773 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:11582639
   |texte=   [Rosacea in the year 2001].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:11582639" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

[Rosacea in the year 2001].

[Rosacea in the year 2001].

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki